CytomX Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2013 | — | -1,684.2% | -1,705.3% |
| FY2014 | — | -586.3% | -597.0% |
| FY2015 | — | -430.5% | -458.7% |
| FY2016 | — | -396.1% | -391.5% |
| FY2017 | — | -64.6% | -60.2% |
| FY2018 | — | -130.9% | -142.2% |
| FY2019 | — | -525.9% | -493.7% |
| FY2020 | — | -117.7% | -94.7% |
| FY2021 | — | -311.0% | -310.5% |
| FY2022 | — | -190.6% | -186.8% |